2008, Number 6
<< Back Next >>
Rev Med Inst Mex Seguro Soc 2008; 46 (6)
Multiple Sclerosis and Epstein-Barr Virus: A Growing Association
Gutiérrez J, Koppel B, Kleiman A, Akfirat G
Language: English
References: 32
Page: 639-642
PDF size: 91.11 Kb.
ABSTRACT
The etiology of multiple sclerosis is an elusive field due to the lack of the usual causeeffect relationship model to explain a disease. In fact, with all the current evidence we start thinking in multiple sclerosis as a multi-factorial disease, where an infective agent on a genetically permissive host can lead to inflammation, demyelination and ultimately to neurological damage with dire consequences for the patients. This review will focus on the role of viruses in multiple sclerosis etiology and give some insight regarding this complicated issue.
REFERENCES
Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol 2005;4:195-202.
Willer CJ, Dyment DA, Risch NJ, Sadovnick AD. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003; 100:12877-12882.
Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation or viral persistence: Infectious and autoimmune disease. Clin Microbiol Rev 2006;19(1):80-94.
Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 15:179-211.
Christensen T, Sorensen PD, Hansen HJ, Moller- Larsen A. Antibodies against a human endogenous retrovirus and the preponderance of Env splice variant in multiple sclerosis patients. Mult Scler 2003; 9:6-15
Reiber H, Ungefehr S, Jacobi C. Intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998;4:111-117
Bray PF, Luka J, Bray PF, Culp KW, Schlight JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis cerebrospinal fluid, and two pentapeptide sequence identifies between EBNA and myelin basic protein. Neurology 1992; 42:1798-1804.
Layh-Schmitt G, Bendl C, Hildt U, Dong-Si T, Juttler E, Schnitzler P, et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 2000;47:652-655.
Krametter D, Niederwieser G, Berghold A, Bimbaum G, Strasser-Fuchs S, Hartung HP, et al. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 2001;7(1):13-18.
Munger KL, Peeling RW, Hernan MA, Chasan- Taber L, Olek MJ, Hankinson SE, et al. Chlamydia pneumonie and risk of multiple sclerosis. Epidemiology 2003;14:141-147.
Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004;3:709-718.
Christensen T. The role of EBV in MS pathogenesis. Int MS J. 2006 May;13(2):52-7
Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 6(4):382-427.
Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002;2(2): 85-95.
Fujinami RS, Zurbriggen A, Powel HC. Monoclonal antibody defines determinant between Theiler’s virus and lipid-like structures. J Neuroimmunol 1988;20(1):25-32.
Duke RC. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J Exp Med. 1989;170(1):59-71.
Srinivasappa JJ, Saegusa BS, Prabhakar MK, Gentry MJ, Buchmeier TJ, Witkor H, et al. Molecular mimicry: frequency of reactivation of monoclonal antiviral antibodies with normal tissues. J Virol 1986;57:397-401.
Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis. JAMA 2001;286:3083-3088.
Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, et al. Temporal relationship between elevation of Epstein-Barr virus antibodies titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293:2496-2500.
Ponsonby AL, van der Mei I, Dwyer T, Blizzard L, Taylor B, Kemp A, et al. Exposure to infant sibling during early life and risk of multiple sclerosis. JAMA 2005; 293:463-469.
Aloitaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291:1875-1879.
Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health 2004; 58: 1032-1035.
Pohl D, Krone B, Rostasy K, Kahler E, Brunner E, Lehnert M, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006; 67:2063-2065.
Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis. Neurology 2004;62:2277-2282.
Henle W, Henle G, Anderson J, Ernberg I, Klein G, Horwitz CA, et al. Antibody response to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci 1987; 84:570-574.
Wandinger KP, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner HJ, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000;55:164-165.
Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, et al. Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:1377-1381.
Perron H, Garson JA, Bedin F, Beseme F, Perenhos- Baccala G, Komurian-Pradel F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple slcerosis. Proc Natl Acad Sci 1997;94:7583-7588.
Opsahl ML, Kennedy PG. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005;128: 516-527.
Liedtke W, MAlessa R, Faustmann PM, Eis-Hubinger AM. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995;1:253-258.
Mirandola P, Stefan P, Brambilla E, Campadelli- Fiume G, Grimaldi LM. Abscense of human herpes virus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 1999;53: 1367-1368.
Rodríguez-Carneros S, Martínez-Vázquez C, Potel- Alvarellos C, Álvarez-Fernández M, Prieto-González JM, Noya-García M, et al. Lack of human herpes virus type 6 DNA in CSF by nested PCR among patients with multiple sclerosis. Rev Clin Esp 2002; 202:588-591.